Clinical Trial Update: Phase 2a Clinical Trial to Evaluate the Efficacy and Safety of HL301 on Radiation Pneumonitis in Non-small Cell Lung Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2a trial evaluating HL301 for efficacy and safety in radiation pneumonitis associated with lung cancer (non-small cell lung cancer). Status currently unkn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Radiation Pneumonitis

Drugs mentioned

• HL301

Snippet

Sponsor: Hanlim Pharm. Co., Ltd. | Conditions: Radiation Pneumonitis, Lung Cancer | Phase 2 | Status: UNKNOWN